Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A
Clinical trial NCT04131036 · RECRUITING
Trial details
- NCT number
- NCT04131036
- Sponsor
- Washington Institute for Coagulation
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-04-04
- Primary completion
- 2026-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.